Approval · Notice of Compliance 7204 · 2005
ADENOSCAN: Notice of Compliance 7204
Issued July 6, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7204
- Date
- July 6, 2005
- Company
- Astellas Pharma Canada IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Coronary vasodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADENOSCAN | 02139294 | Cancelled Post Market |
Medicinal ingredients
- ADENOSINE 3 MG per ML